A Study of Multi-electrode Circular Irreversible Electroporation (IRE) Catheter and Multi-Channel IRE Generator in Paroxysmal Atrial Fibrillation (AF)
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 142 participants.
Also called NCT05552963
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 142 participants
- Sponsor
- Registry
-
NCT05552963
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- China
- Registry status
- Completed
Technical summary
Registry record NCT05552963. Allocation not applicable; no masking; primary purpose treatment. Start 2022-12-07 (actual); primary completion 2024-12-18 (actual). Results posted on 2026-01-06.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Study of Multi-electrode Circular Irreversible Electroporation (IRE) Catheter and Multi-Channel IRE Generator in Paroxysmal Atrial Fibrillation (AF)
- Acronym
- AFIRE
- Condition
- Refractory Paroxysmal Atrial Fibrillation
- Intervention (Device)
- Multi-Channel Irreversible Electroporation (IRE) Generator
- Intervention (Device)
- Multi-Channel Circular IRE Catheter
- Lead sponsor
- Biosense Webster, Inc.
Record details
- Record id
cardio:ct-nct05552963- Content hash
f435f6eb53af1977d57cbe3d4ebc909e5099d586ee82baf4186bc0654c10358b